Adverum Biotechnologies SG&A Expense (Quarterly) Analysis

Adverum Biotechnologies Inc (ADVM)

8.25 -0.50 (-5.71%) USD | NASDAQ | May 16, 16:00

8.235 -0.02 (-0.18%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2013. Upgrade now.

Date	Value
March 31, 2024	11.43M
December 31, 2023	10.88M
September 30, 2023	13.79M
June 30, 2023	12.47M
March 31, 2023	12.78M
December 31, 2022	11.74M
September 30, 2022	17.19M
June 30, 2022	13.76M
March 31, 2022	15.17M
December 31, 2021	11.90M
September 30, 2021	14.45M
June 30, 2021	21.93M
March 31, 2021	16.16M
December 31, 2020	13.65M
September 30, 2020	11.35M
June 30, 2020	10.60M
March 31, 2020	9.04M
December 31, 2019	8.279M
September 30, 2019	7.389M
June 30, 2019	7.132M
March 31, 2019	5.576M
December 31, 2018	5.187M
September 30, 2018	4.826M

Date	Value
June 30, 2018	9.179M
March 31, 2018	5.368M
December 31, 2017	4.042M
September 30, 2017	4.762M
June 30, 2017	4.064M
March 31, 2017	7.989M
December 31, 2016	4.777M
September 30, 2016	6.146M
June 30, 2016	5.114M
March 31, 2016	8.318M
December 31, 2015	5.374M
September 30, 2015	7.631M
June 30, 2015	4.959M
March 31, 2015	4.143M
December 31, 2014	3.38M
September 30, 2014	2.398M
June 30, 2014	1.494M
March 31, 2014	0.726M
December 31, 2013	1.19M
September 30, 2013	0.258M
June 30, 2013	0.194M
March 31, 2013	0.141M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

7.132M

Minimum

Jun 2019

21.93M

Maximum

Jun 2021

12.55M

Average

12.18M

Median

SG&A Expense (Quarterly) Benchmarks